candidiasis
Information
- Disease name
- candidiasis
- Disease ID
- DOID:1508
- Description
- "An opportunistic mycosis that involves fungal infection of the mouth, throat, skin, scalp, vagina, fingers, nails, bronchi, lungs, heart and brain by Candida species, of which Candida albicans is the most common. Systemic Candida infections are usually confined to severely immunocompromised persons." [url:http\://en.wikipedia.org/wiki/Candidiasis, url:http\://mycology.adelaide.edu.au/Mycoses/Cutaneous/Candidiasis/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05707156 | Completed | Prospective Observational Study on the Incidence of Opportunistic Fungal Infections | July 5, 2023 | January 5, 2024 | |
| NCT00000744 | Completed | N/A | A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women | December 1995 | |
| NCT00000788 | Completed | Phase 1 | A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone | June 1994 | |
| NCT00001107 | Completed | Phase 4 | Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants | November 2005 | |
| NCT00001542 | Completed | Phase 4 | Fluconazole Prophylaxis of Thrush in AIDS | July 1996 | November 2001 |
| NCT00001810 | Completed | Phase 3 | An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections | April 1999 | October 2000 |
| NCT00001937 | Completed | Phase 3 | Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients | November 1999 | December 2000 |
| NCT00002038 | Completed | N/A | Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy | ||
| NCT00005912 | Completed | Phase 1 | Voriconazole to Prevent Systemic Fungal Infections in Children | June 2000 | January 2001 |
| NCT00036179 | Completed | Phase 2 | Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis | February 27, 1999 | January 27, 2002 |
| NCT00037219 | Completed | Phase 2 | The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. | August 2001 | November 2002 |
| NCT00041704 | Completed | Phase 2 | The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) | August 2002 | August 2004 |
| NCT00056368 | Completed | Phase 3 | The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis | March 2003 | October 2004 |
| NCT00058682 | Completed | Phase 3 | Anidulafungin Versus Fluconazole in the Treatment of Candidemia | April 2003 | January 2005 |
| NCT00082524 | Completed | Phase 2 | Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) | April 2004 | July 2007 |
| NCT00083343 | Completed | Phase 2 | Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) | May 2004 | February 2006 |
| NCT01202253 | Completed | Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom | February 2011 | May 2011 | |
| NCT01230814 | Completed | Phase 2 | Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women | April 2011 | August 2013 |
| NCT01273922 | Completed | Phase 1 | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida | January 2011 | December 2011 |
| NCT01322698 | Completed | Staging Candidiasis in ICU Patients | October 2011 | October 2014 | |
| NCT01447407 | Completed | Phase 1 | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine | September 2011 | December 2012 |
| NCT01919931 | Completed | Immunological Interaction Between the Host and Candida Albicans Biofilm | March 2013 | January 2016 | |
| NCT02391532 | Completed | N/A | Effect of Probiotic Bacteria on Oral Candida in Frail Elderly | September 2013 | June 2015 |
| NCT02493738 | Completed | Phase 1 | A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers | July 2015 | October 2015 |
| NCT02641717 | Completed | N/A | Validity of Patient-Collected Wet Mounts | November 2015 | August 2016 |
| NCT02666716 | Completed | Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients | May 2015 | March 2016 | |
| NCT02860845 | Completed | Phase 4 | Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections | July 12, 2016 | November 30, 2017 |
| NCT03136081 | Completed | Candida Host Defense Response After Septic Shock in the Critically Ill | June 2014 | May 2015 | |
| NCT03203551 | Completed | N/A | Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. | September 1, 2014 | July 1, 2016 |
| NCT04122560 | Completed | Phase 4 | Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration | November 30, 2019 | March 23, 2021 |
| NCT05044156 | Completed | Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women | October 21, 2021 | March 6, 2022 | |
| NCT00000676 | Completed | Phase 3 | Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) | November 1993 | |
| NCT00099775 | Completed | Phase 3 | Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units | December 2004 | September 2005 |
| NCT00105144 | Completed | Phase 3 | Study of Micafungin in Patients With Invasive Candidiasis or Candidemia | September 2004 | April 2006 |
| NCT00106288 | Completed | Phase 3 | Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia | January 2003 | December 2005 |
| NCT00109525 | Completed | Early Diagnosis of Candidiasis in Premature Infants | March 2004 | December 2009 | |
| NCT00138502 | Completed | Funguria in Hospitalized Patients | September 17, 2001 | December 8, 2008 | |
| NCT00163111 | Completed | Phase 3 | A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. | September 1998 | May 2003 |
| NCT00313131 | Completed | Phase 3 | Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments | January 2004 | May 2005 |
| NCT00330395 | Completed | Phase 2 | Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) | May 2006 | October 2006 |
| NCT00388167 | Completed | Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection | March 2004 | February 2008 | |
| NCT00496197 | Completed | Phase 4 | Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis | July 2007 | June 2010 |
| NCT00612963 | Completed | Novel Rinse to Treat in Oral Candidiasis in Cancer Patients | April 2007 | May 2009 | |
| NCT00647907 | Completed | Phase 4 | A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections | April 2003 | May 2004 |
| NCT00734539 | Completed | Phase 3 | Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight | November 2008 | April 2013 |
| NCT00739934 | Completed | Phase 2 | Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection | December 2008 | October 2009 |
| NCT00784368 | Completed | Phase 3 | A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection | January 2008 | May 2009 |
| NCT00797420 | Completed | Phase 1 | Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers | November 2008 | September 2011 |
| NCT01102387 | Completed | Phase 2 | Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections | February 2010 | July 2011 |
| NCT03828773 | Recruiting | N/A | PTX3-targeted Antifungal Prophylaxis | February 11, 2019 | November 30, 2025 |
| NCT05235711 | Recruiting | The Role Of Interferon-gamma In Immune Responses To Invasive Candidiasis | February 10, 2022 | August 2024 | |
| NCT00805740 | Terminated | Phase 3 | An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida | April 2009 | June 2012 |
| NCT00692783 | Terminated | Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility | May 2008 | January 2009 | |
| NCT00806351 | Terminated | Phase 3 | An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System | August 2009 | October 2011 |
| NCT00815516 | Terminated | Phase 3 | Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis | February 2013 | December 2014 |
| NCT00095316 | Terminated | Phase 3 | Caspofungin Study for Fungal Infections in Adults in Critical Care Settings | October 2004 | September 2006 |
| NCT02646800 | Terminated | Phase 4 | Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp | March 21, 2014 | December 21, 2014 |
| NCT01092832 | Terminated | Phase 3 | A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients | October 2010 | June 2013 |
| NCT01982071 | Terminated | Phase 4 | A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia | September 26, 2013 | August 28, 2015 |
| NCT04502277 | Unknown status | Early Phase 1 | Bioavailability of Flucanazole | September 1, 2020 | January 31, 2021 |
| NCT01315925 | Unknown status | Pre-hospital Risk Factors for Invasive Fungal Infection | January 2010 | ||
| NCT00889356 | Unknown status | Phase 3 | Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis | September 2009 | March 2010 |
| NCT02145832 | Unknown status | Phase 2/Phase 3 | Fluconazole Versus Micafungin in Neonates With Candidiasis | June 2014 | May 2017 |
| NCT01253954 | Unknown status | A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China | November 2009 | April 2011 | |
| NCT00304772 | Withdrawn | Phase 4 | Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients | August 2006 | December 2008 |
- Disase is a (Disease Ontology)
- DOID:2473
- Cross Reference ID (Disease Ontology)
- ICD10CM:B37
- Cross Reference ID (Disease Ontology)
- ICD9CM:112
- Cross Reference ID (Disease Ontology)
- MESH:D002177
- Cross Reference ID (Disease Ontology)
- NCI:C26711
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154403005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0006840
- Exact Synonym (Disease Ontology)
- Disseminated candidiasis
- Exact Synonym (Disease Ontology)
- systemic candidiasis
- ICD10 preferred id (Insert disease from ICD10)
- D0000633
- ICD10 class code (Insert disease from ICD10)
- B37
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002177